Form D · Venture Capital Fund

MedScience Ventures, L.P.

Boston, MA · CIK 0001679701

Offering snapshot reported Mar 14, 2019 · SEC filing

Reported sold
$4.58M
Offering amount: $10M
Investors reported
15
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jul 1, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.29M$4.58MJul 15, 2016: $4,250,000.00Jul 15, 2016Mar 14, 2019: $4,575,000.00Mar 14, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,250,000 → $4,575,000
  • Reported investors12 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 14, 2019Amendment$4,575,000$325,000vs Jul 15, 201615SEC filing
Jul 15, 2016Initial$4,250,000No comparison12SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-267132

Source: Form D, filed Mar 14, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MEDSCIENCE VENTURES, L.P.

Investment adviser: MEDSCIENCE VENTURES LLC

Gross asset value
$4.67M
Beneficial owners
16
ADV minimum commitment
$50K

Reported in Form ADV on Feb 15, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Custodian BANK OF AMERICA FRAMINGHAM, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No
Filing source

Form ADV 1821548 · Feb 15, 2024 · Schedule D 7.B.(1), fund 805-8927672537

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stefano Ciampolini Executive
Christopher Ford Executive
Sherwyn Hung Executive
Bret Siarkowski Executive
Nick Wu Executive
Lidong Zhang Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Medscience Ventures Llc 745 Atlantic Avenue
Boston, MA, 02111